Grégory Delattre
About Grégory Delattre
Grégory Delattre is the Launch Acceleration Lead for Europe Cardiology (HCM) at Bristol Myers Squibb and serves as Vice President and Board Member at ACIP in Paris, Île-de-France, France.
Company
Grégory Delattre is currently working at Bristol Myers Squibb, based in Paris, Île-de-France, France. He holds the position of Launch Acceleration Lead in the Europe Cardiology (HCM) division. Bristol Myers Squibb is a global biopharmaceutical company focusing on research, development, and commercialization across multiple therapeutic areas.
Title
Grégory Delattre serves as the Launch Acceleration Lead - Europe Cardiology (HCM) at Bristol Myers Squibb. Additionally, he is the Vice President and a Board Member at ACIP, also located in Paris, Île-de-France, France.
Education and Expertise
Grégory Delattre has a strong academic background in the sciences. He earned a D.Phil. in Neuroscience from University College London between 2010 and 2013. Prior to that, he completed an M.Sc. in Pharmacology at the University of Oxford in 2010. He also holds a B.Sc. in Engineering-Biology from École Polytechnique, completed in 2009. His expertise spans neuroscience, pharmacology, and structural immunology.
Background
Grégory Delattre has a comprehensive background in the healthcare industry with over 10 years of experience. He began his career with an internship at Andes Hostel, Santiago, Chile, and has worked in various roles in different organizations, including as an Officer in the French Army Foreign Legion. His experience includes roles as a Strategy Consultant at ZS Associates and various strategic and analytical positions at Bristol Myers Squibb.
Achievements
Grégory Delattre has a proven track record in driving business growth and innovation within the healthcare industry. He has led strategic and commercial initiatives, developed operational effectiveness plans, and fostered cross-functional team engagement. He leverages finance and association management skills at ACIP Santé to foster collaboration, advocacy, and education. He has also been involved in organizing and participating in roundtables and events addressing healthcare challenges and opportunities globally.